Niraparib and Bevacizumab Maintenance Therapy in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor
Condition(s):Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP InhibitorLast Updated:July 12, 2021Recruiting